Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis: a Double-Blind Randomized Crossover Study

NCT00981084 is registered in ClinicalTrials.gov with University of Missouri, Kansas City as lead sponsor.

NCT NCT00981084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00981084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis: a Double-Blind Randomized Crossover Study
Lead sponsor
University of Missouri, Kansas City
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2009
Completion date
April 30, 2011
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis